Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115834675 | 11583467 | 5 | F | 20160824 | 20151001 | 20160907 | EXP | US-ACORDA-ACO_109686_2015 | ACORDA | 0.00 | M | Y | 61.22000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115834675 | 11583467 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | PZYG | 22250 | 10 | MG | TABLET | BID | |||||
| 115834675 | 11583467 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | 30 ?G, WEEKLY ON FRIDAYS | Y | U | 0 | 30 | UG | /wk | |||||
| 115834675 | 11583467 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Unknown | 30 ?G, ONCE WEEKLY | Y | U | 0 | 30 | UG | ||||||
| 115834675 | 11583467 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | 15 ?G, UNK | Y | U | 0 | 15 | UG | |||||||
| 115834675 | 11583467 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 600 MG, UNK | U | 0 | 600 | MG | |||||||
| 115834675 | 11583467 | 6 | C | Meclizine hcl | MECLIZINE HYDROCHLORIDE | 1 | Unknown | UNK, DAILY | U | 0 | QD | ||||||||
| 115834675 | 11583467 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115834675 | 11583467 | 1 | Gait disturbance |
| 115834675 | 11583467 | 2 | Multiple sclerosis |
| 115834675 | 11583467 | 5 | Product used for unknown indication |
| 115834675 | 11583467 | 6 | Dizziness |
| 115834675 | 11583467 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115834675 | 11583467 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115834675 | 11583467 | Anxiety | |
| 115834675 | 11583467 | Asthenia | |
| 115834675 | 11583467 | Back pain | |
| 115834675 | 11583467 | Dyspnoea | |
| 115834675 | 11583467 | Dysstasia | |
| 115834675 | 11583467 | Fall | |
| 115834675 | 11583467 | Fatigue | |
| 115834675 | 11583467 | Feeling abnormal | |
| 115834675 | 11583467 | Fine motor skill dysfunction | |
| 115834675 | 11583467 | Gastrointestinal haemorrhage | |
| 115834675 | 11583467 | Headache | |
| 115834675 | 11583467 | Hypoaesthesia | |
| 115834675 | 11583467 | Ill-defined disorder | |
| 115834675 | 11583467 | Malaise | |
| 115834675 | 11583467 | Memory impairment | |
| 115834675 | 11583467 | Multiple sclerosis | |
| 115834675 | 11583467 | Musculoskeletal discomfort | |
| 115834675 | 11583467 | Musculoskeletal pain | |
| 115834675 | 11583467 | Musculoskeletal stiffness | |
| 115834675 | 11583467 | Pain | |
| 115834675 | 11583467 | Paralysis | |
| 115834675 | 11583467 | Quadriplegia | |
| 115834675 | 11583467 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115834675 | 11583467 | 1 | 20130802 | 0 | ||
| 115834675 | 11583467 | 2 | 201309 | 201412 | 0 | |
| 115834675 | 11583467 | 3 | 20150304 | 0 | ||
| 115834675 | 11583467 | 6 | 2013 | 0 | ||
| 115834675 | 11583467 | 7 | 2014 | 0 |